Joachim Lundahl

Joachim Lundahl

Auto-generated profile, based on publicly available information

Joachim Lundahl

Department of Clinical Science and Education, South Hospital Karolinska Institutet Stockholm Sweden

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2024 in Allergy
Verified
Journal Article
Open access
HTHelena Thulin
Helena Thulin
LMLadan Mansouri
Ladan Mansouri
MAMaria Altman
Maria Altman
SMSimon Kebede Merid
Simon Kebede Merid
JLJoachim Lundahl
Joachim Lundahl
JSJesper Säfholm
Jesper Säfholm
Background: Noninvasive biomarkers for diagnosing and monitoring eosinophilic esophagitis (EoE) are currently lacking. This study evaluates 20 biomarkers in serum and saliva, aiming to assess their diagnostic potential in pediatric EoE patients and healthy individuals.Methods: Blood and saliva from children undergoing upper endoscopy were analyzed for biomarkers, including absolute eosinophil count (AEC), eosinophil‐derived neurotoxin (EDN), total and specific IgG4‐antibodies (sIgG4), specific IgE‐antibodies (sIgE) and 15‐hydroxyeicosatetraenoic acid (15(S)‐HETE). Some patients participated twice, forming a longitudinal cohort. The ability to use the biomarkers to predict the EoE diagnosis was evaluated.Results: Analysis from 105 children divided into active EoE, remission, and healthy, revealed elevated levels of serum biomarkers (AEC, EDN, 15(S)‐HETE, sIgG4, and sIgE) in active EoE compared to healthy individuals. A combination of biomarkers (AEC, EDN, sIgE to egg white and wheat) and symptoms showed an AUC of 0.92 in distinguishing between the three groups. We further showed that optimal cutoff values for these biomarkers could discriminate between active EoE and healthy with a sensitivity of 88% and a specificity of 100% in distinguishing EoE (active and in remission) from healthy. Longitudinally, levels of EDN, sIgG4 to Bos d 4, Bos d 5, Bos d 8, gliadin, and birch, and sIgE to milk decreased in patients progressing from active EoE to remission (p <.05).Conclusions: This study identified novel biomarkers associated with EoE and proposes a panel, together with symptoms, for effective discrimination between active EoE, EoE in remission, and healthy individuals. The findings may contribute to a less invasive diagnostic method and may be a potential surveillance tool for pediatric EoE patients.

21 September 2020 in Immunology
Verified
Journal Article
Open access
PDF file
FKFrida Kalm
Frida Kalm
LMLadan Mansouri
Ladan Mansouri
ARAman Russom
Aman Russom
JLJoachim Lundahl
Joachim Lundahl
ANAnna Nopp
Anna Nopp
Summary: Basophils are known for their role in allergic inflammation, which makes them suitable targets in allergy diagnostics such as the basophil activation test (BAT) and the microfluidic immunoaffinity basophil activation test (miBAT). Beside their role in allergy, basophils have an immune modulatory role in both innate immunity and adaptive immunity. To accomplish this mission, basophils depend on the capability to migrate from blood to extravascular tissues, which includes interactions with endothelial cells, extracellular matrix and soluble mediators. Their receptor repertoire is well known, but less is known how these receptor–ligand interactions impact the degranulation process and the responsiveness to subsequent activation. As the consequences of these interactions are crucial to fully appreciate the role of basophils in immune modulation and to enable optimization of the miBAT, we explored how basophil activation status is regulated by cytokines and cross‐linking of adhesion molecules. The expression of adhesion molecules and activation markers on basophils from healthy blood donors was analysed by flow cytometry. Cross‐linking of CD203c, CD62L, CD11b and CD49d induced a significant upregulation of CD63 and CD203c. To mimic in vivo conditions, valid also for miBAT, CD62L and CD49d were cross‐linked followed by IgE‐dependent activation (anti‐IgE), which caused a reduced CD63 expression compared with anti‐IgE activation only. IL‐3 and IL‐33 priming caused increased CD63 expression after IgE‐independent activation (fMLP). Together, our data suggest that mechanisms operational both in the microfluidic chip and in vivo during basophil adhesion may impact basophil anaphylactic and piecemeal degranulation procedures and hence their immune regulatory function.

20 January 2012 in Journal of Clinical Apheresis
Verified
Journal Article
Open access
PDF file
VMV. Muratov
V. Muratov
JPJ.M. Paulsson
J.M. Paulsson
KEK. Elvin
K. Elvin
RLR. Löfberg
R. Löfberg
JLJ. Lundahl
J. Lundahl
Leukocyte apheresis primarily used for treatment of inflammatory diseases such as inflammatory bowel disease (IBD). Beside an effect of the apheresis column, the plastic lines in the apheresis system might also have an effect due to interaction between the plastic surfaces and circulating leukocytes and plasma proteins. We recently reported generation of LL‐37 in the plastic lines during leukocyte adsorbing apheresis. This generation might have a positive impact on the immunologic tolerance and therefore be one operational mechanism by which the apheresis treatment executes its effect. In the present study, we report a significant generation of sIL‐1RI in the apheresis lines that is initially absorbed by the LCAP device. This finding, together with our previous data on IL‐1Ra indicate that important members of the IL‐1 family are significantly altered during the LCAP treatment of patients with IBD. Since IL‐1 and its antagonists are important for regulation of inflammatory processes in IBD, we speculate that the LCAP related changes in sIL‐1RI and IL‐1Ra might impact the clinical outcome. These findings have to be taken into consideration when designing new apheresis techniques as well as sham‐controlled studies. J. Clin. Apheresis, 2012.